Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1

Neuron

Volumn 30, Issue 1, 2001, Pages 121-134

  Torres, Gonzalo E ^a   Yao, Wei Dong ^a   Mohn, Amy R ^a   Quan, Hui ^a   Kim, Kyeong Man ^a   Levey, Allan I ^b   Staudinger, Jeff ^c   Caron, Marc G ^a  

^a DUKE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DOPAMINE TRANSPORTER; PROTEIN INTERACTING WITH PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SYNAPSE;

EID: 0035026044     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(01)00267-7     Document Type: Article

References (50)

1. Amara S.G., Kuhar M.J. Neurotransmitter transporters. recent progress Annu. Rev. Neurosci. 16:1993;73-93.
2. Amara S.G., Sonders M.S. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend. 51:1998;87-96.
3. Apparsundaram S., Schroeter S., Giovanetti E., Blakely R.D. Acute regulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins J. Pharmacol. Exp. Ther. 287:1998;744-751.
4. Barker E.L., Blakely R.D. Norepinephrine and serotonin transporters. molecular targets of antidepressant drugs Bloom F.E., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress:1995;Raven Press, Philadelphia, PN. 321-333.pp.
5. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mossner R., Westphal H., Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 53:1998;649-655.
6. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
7. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., Levey A.I. The dopamine transporter. immunochemical characterization and localization in brain J. Neurosci. 15:1995;1714-1723.
8. Clarkson E.D., Rosa F.G.L., Edwards-Prasad J., Weiland D.A., Witta S.E., Freed C.R., Prasad K.N. Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells. Proc. Natl. Acad. Sci. USA. 95:1998;1265-1270.
9. Clarkson E.D., Edwards-Prasad J., Freed C.R., Prasad K.N. Immortalized dopamine neurons. a model to study neurotoxicity and neuroprotection Proc. Soc. Exp. Biol. Med. 222:1999;157-163.
10. Copeland B.J., Vogelsberg V., Neff N.H., Hadjiconstantinou M. Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther. 277:1996;1527-1532.
11. Daniels G.M., Amara S.G. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274:1999;35794-35801.
12. De Camilli P., Cameron R., Greengard P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections. J. Cell Biol. 96:1983;1337-1354.
13. Doyle D.A., Lee A., Lewis J., Kim E., Sheng M., MacKinnon R. Crystal structures of a complexed and peptide-free membrane protein-binding domain. molecular basis of peptide recognition by PDZ Cell. 85:1996;1067-1076.
14. Fanning A.S., Anderson J.M. PDZ domains. fundamental building blocks in the organization of protein complexes at the plasma membrane J. Clin. Invest. 103:1999;767-772.
15. Ferguson S.S., Zhang J., Barak L.S., Caron M.G. Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci. 62:1998;1561-1565.
16. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. (1993). Trends Pharmacol. Sci. 14:1993;43-49.
17. Giros B., el Mestikawy S., Bertrand L., Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295:1991;149-154.
18. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
19. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
20. + exchange. Nature. 392:1998;626-630.
21. Hersch S.M., Yi H., Heilman C.J., Edwards R.H., Levey A.I. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388:1997;211-227.
22. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. USA. 95:1998;4029-4034. a.
23. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18:1998;1979-1986. b.
24. Kilty J.E., Lorang D., Amara S.G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science. 254:1991;578-579.
25. Kornau H.C., Seeburg P.H., Kennedy M.B. Interaction of ion channels with PDZ domain proteins. Curr. Opin. Neurobiol. 7:1997;368-373.
26. Manivet P., Mouillet-Richard S., Callebert J., Nebigil C.G., Maroteaux L., Hosoda S., Kellermann O., Launay J.M. PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. J. Biol. Chem. 275:2000;9324-9331.
27. Melikian H.E., Buckley K.M. Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19:1999;7699-7710.
28. Nirenberg M.J., Chan J., Pohorille A., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. The dopamine transporter. comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens J. Neurosci. 17:1995;6899-6997.
29. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16:1996;436-447.
30. Nirenberg M.J., Chan J., Liu Y., Edwards R.H., Pickel V.M. Vesicular monoamine transporter-2. immunogold localization in striatal axons and terminals Synapse. 26:1997;194-198.
31. O'Brien R.J., Lau L.F., Huganir R.L. Molecular mechanisms of glutamate receptor clustering at excitatory synapses. Curr. Opin. Neurobiol. 8:1998;364-369.
32. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
33. Pickel V.M., Chan J. Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens. J. Neurosci. 19:1999;7356-7366.
34. Qian Y., Galli A., Ramamoorthy S., Risso S., DeFelice L.J., Blakely R.D. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17:1997;45-57.
35. Ramamoorthy S., Giovanetti E., Qian Y., Blakely R.D. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem. 273:1998;2458-2466.
36. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
37. Sheng M., Wyszynski M. Ion channel targeting in neurons. Bioessays. 19:1997;847-853.
38. Shimada S., Kitayama S., Lin C.L., Patel A., Nanthakumar E., Gregor P., Kuhar M., Uhl G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science. 254:1991;576-578.
39. Songyang Z., Fanning A.S., Fu C., Xu J., Marfatia S.M., Chishti A.H., Crompton A., Chan A.C., Anderson J.M., Cantley L.C. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science. 275:1997;73-77.
40. Staudinger J., Zhou J., Burgess R., Elledge S.J., Olson E.N. PICK1. a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system J. Cell Biol. 128:1995;263-271.
41. Staudinger J., Lu J., Olson E.N. Specific interaction of the PDZ domain protein PICK1 with the COOH terminus of protein kinase C-alpha. J. Biol. Chem. 272:1996;32019-32024.
42. Tao-Cheng J.H., Zhou F.C. Differential polarization of serotonin transporters in axons versus soma-dendrites. an immunogold electron microscopy study Neuroscience. 94:1999;821-830.
43. Torres R., Firestein B.L., Dong H., Staudinger J., Olson E.N., Huganir R.L., Bredt D.S., Gale N.W., Yancopoulos G.D. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron. 21:1998;1453-1463.
44. Tsunoda S., Sierralta J., Sun Y., Bodner R., Suzuki E., Becker A., Socolich M., Zuker C.S. A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade. Nature. 388:1997;243-249.
45. Usdin T.B., Mezey E., Chen C., Brownstein M.J., Hoffman B.J. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. USA. 88:1991;11168-11171.
46. Vandenbergh D.J., Persico A.M., Uhl G.R. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res. Mol. Brain Res. 15:1992;161-166.
47. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272:1997;15541-15546.
48. Xia J., Zhang X., Staudinger J., Huganir R.H. Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron. 22:1999;179-187.
49. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3:2000;465-471.
50. Zhou F.C., Tao-Cheng J.H., Segu L., Patel T., Wang Y. Serotonin transporters are located on the axons beyond the synaptic junctions. anatomical and functional evidence Brain Res. 805:1998;241-254.